Abstract
Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Current Signal Transduction Therapy
Title:Current Biomarkers for Lung Cancer
Volume: 9 Issue: 3
Author(s): Kaifei Wang, Zhaohui Huang, Ruilin Wang, Jin Qian, Zhenhua Zuo, Yaping Li, Xiaoyan Yao and Xizhou Guan
Affiliation:
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Abstract: Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Export Options
About this article
Cite this article as:
Wang Kaifei, Huang Zhaohui, Wang Ruilin, Qian Jin, Zuo Zhenhua, Li Yaping, Yao Xiaoyan and Guan Xizhou, Current Biomarkers for Lung Cancer, Current Signal Transduction Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574362409666140911225531
DOI https://dx.doi.org/10.2174/1574362409666140911225531 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Current Medicinal Chemistry Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Current Drug Metabolism Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma
Mini-Reviews in Medicinal Chemistry Main Nutritional and Environmental Risk Factors in Children with Leukemia from a Public Hospital of the State of Guanajuato, Mexico
Current Cancer Therapy Reviews Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Current Drug Metabolism IMGT Colliers de Perles: Standardized Sequence-Structure Representations of the IgSF and MhcSF Superfamily Domains
Current Bioinformatics Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Computational Approaches for Translational Oncology: Concepts and Patents
Recent Patents on Anti-Cancer Drug Discovery The Shape of the Messenger: Using Protein Structure Information to Design Novel Cytokine-based Therapeutics
Current Pharmaceutical Design Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Photodynamic Therapy: The Development of New Photosensitisers
Anti-Cancer Agents in Medicinal Chemistry Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid
Anti-Cancer Agents in Medicinal Chemistry Chitosan and its Derivatives as Chemical Drug Delivery Carriers
Current Organic Chemistry NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Role of the Akt Pathway in Prostate Cancer
Current Cancer Drug Targets Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy